Atlas Trials

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)

Clinical trial NCT01857115 · COMPLETED

Trial details

NCT number
NCT01857115
Sponsor
European Myeloma Network B.V.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-04-01
Primary completion
2013-11-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.